Royalty Pharma board increases quarterly dividend 5.3% to 20c per share

Royalty Pharma announced that its board of directors has declared a dividend for the first quarter of 2023 of $0.20 per Class A share, reflecting a 5.3% increase in the company’s quarterly dividend over the previous quarter’s dividend. The dividend will be paid on March 15, 2023 to shareholders of record at the close of business on February 16, 2023. "We are pleased to once again announce an increase to our dividend," said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. "We are committed to returning capital to our shareholders through our attractive dividend while retaining financial flexibility to fund innovation. We continue to see significant opportunities for value-enhancing growth as the demand for capital in the biopharma ecosystem remains very strong."